Synopsis of recent research by authors named "Rebekka Salgo"
- Rebekka Salgo's research primarily focuses on the intersection of immunology and dermatology, with a significant emphasis on understanding the impact of treatments like sirolimus and topical calcineurin inhibitors on malignancy and skin conditions such as psoriasis and atopic dermatitis.
- Her systematic reviews and meta-analyses indicate that immunosuppressive therapies used in kidney transplantation and chronic skin diseases can influence the risk of malignancy and cardiovascular morbidity, highlighting the need for careful risk-benefit analysis in treatment choices.
- Salgo's studies employ advanced methodologies, such as microdialysis, to monitor skin conditions at a molecular level, revealing insights into the efficacy and safety of therapies that can have systemic effects on patients.
